Merck & Co. manufactures the type-2 diabetes drug Janumet XR, which contains a combination of sitagliptin and metformin (extended-release). Unfortunately, a growing number of studies have linked sitagliptin to a possible risk of thyroid cancer and pancreatic cancer. Our lawyers are concerned that Merck is putting profits over public safety by not warning about the danger.
Janumet XR Class Action Lawsuit Information: If you or your loved one was injured by Janumet XR, contact our lawyers immediately for a free case consultation. If you decide to join a class action lawsuit, you could receive compensation for your injury, medical expenses, and more.
Litigation Centralizes 150 Lawsuits in Federal Court
October 17, 2013 – According to this update from the U.S. Judicial Panel on Multi-district Litigation (JPML), over 150 people who developed pancreatic cancer after taking a diabetes drug have filed lawsuits. Many of these lawsuits involve injuries caused by sitagliptin, an ingredient in Janumet XR.
If you developed pancreatic cancer after using Janumet XR, you may qualify to join the litigation: In RE: Incretin Mimetics Products Liability Litigation (MDL No. 2452)
What is the problem?
The lawyers at Schmidt & Clark, LLP are nationally-recognized as class action attorneys, but we are filing individual lawsuits instead of a Janumet XR class action lawsuit. We are concerned that a class action is not the best way to maximize each client’s individual financial recovery. There is already a centralized litigation in federal court, but it is not a class action. Instead, plaintiffs are filing individual lawsuits and retaining their own lawyer.
You could be eligible for compensation, including:
- Physical and emotional pain and suffering
- Medical treatment (past and future)
- Lost wages
- Disability or other long-term injuries
- Wrongful death of a family member
- Punitive damages
About Class Action Lawsuits
Class action lawsuits consolidate many individual legal claims into one lawsuit. All of the plaintiffs are represented by one person (called the “class representative”), and only that person’s case is eligible to go to trial. If a jury awards compensation or lawyers negotiate a settlement, everyone in the class action shares it equally.
Why Our Law Firm is Filing Individual Lawsuits Opposed to a Janumet XR Class Action
Class action lawsuits can have major disadvantages for people who are severely injured by pharmaceutical drugs. Our lawyers are concerned that plaintiffs in a class action might be forced into a “low-ball settlement” or high attorneys’ fees. Most plaintiffs in a class action never get to take their case to trial. Even if your case was selected to go to trial and a jury awarded you compensation, you would have to divide it with other people in the class action lawsuit.
This is why our lawyers are filing individual lawsuits. Fortunately, many lawsuits have already been filed, and if you decide to pursue litigation, you won’t be alone. In most cases, we represent our clients on a contingency-fee. This means you pay nothing unless we win a favorable outcome in your case.
Free Janumet XR Class Action Lawsuit Information
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Janumet XR lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.
Free Janumet XR Class Action Information: Again, if you or a loved one was injured by thyroid cancer or pancreatic cancer from Janumet XR, you should contact our law firm immediately. You could receive compensation for your injuries, and our lawyers can help.